Evidence map›Paper›PMID 39991154›Full record

ArticleFrontiers in immunology2025

Corrigendum: The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases.

Mariana Reste, Kristi Ajazi, Ayca Sayi-Yazgan, Radmila Jankovic, Biljana Bufan, Sven Brandau, Espen S Bækkevold, Florent Petitprez, Malin Lindstedt, Gosse J Adema and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Mariana Reste *Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
Kristi Ajazi *Department of Immunotechnology, Lund University, Lund, Sweden.
Ayca Sayi-YazganDepartment of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Technical University, Istanbul, Türkiye.
Radmila JankovicFaculty of Medicine, Institute of Pathology, University of Belgrade, Belgrade, Serbia.
Biljana BufanDepartment of Microbiology and Immunology, University of Belgrade - Faculty of Pharmacy, Belgrade, Serbia.
Sven BrandauExperimental and Translational Research, Department of Otorhinolaryngology, University Hospital Essen, Essen, Germany.
Espen S BækkevoldDepartment of Pathology, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Florent PetitprezCentre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom.
Malin LindstedtDepartment of Immunotechnology, Lund University, Lund, Sweden.
Gosse J AdemaRadiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
Catarina R AlmeidaInstitute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2024.1439413.].

Indexed as

anti-tumor immunityautoimmunitydendritic cells (DC)tertiary lymphoid organs (TLO)tertiary lymphoid structures (TLS)

Identifiers

PMID39991154
PMCPMC11843002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.